Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy
Jenna L. Carter(Wayne State University), Yubin Ge(Wayne State University)
Cited by 216
Related Papers
Truncated WT1 mutants alter the subnuclear localization of the wild-type protein.
|Proceedings of the National Academy of Sciences|1995|161
Inhibition of Mcl-1 enhances cell death induced by the Bcl-2-selective inhibitor ABT-199 in acute myeloid leukemia cells
|Signal Transduction and Targeted Therapy|2017|126
Panobinostat Enhances Cytarabine and Daunorubicin Sensitivities in AML Cells through Suppressing the Expression of BRCA1, CHK1, and Rad51
|PLoS ONE|2013|93
Inhibition of <scp>XPO</scp>1 enhances cell death induced by <scp>ABT</scp>‐199 in acute myeloid leukaemia via Mcl‐1
|Journal of Cellular and Molecular Medicine|2018|63
CHK1 plays a critical role in the anti-leukemic activity of the wee1 inhibitor MK-1775 in acute myeloid leukemia cells
|Journal of Hematology & Oncology|2014|52